Immunoliposome-mediated drug delivery to Plasmodium -infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy-Reference-Cited by-同舟云学术

Immunoliposome-mediated drug delivery to Plasmodium -infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy

Published:2015-07 Issue: Volume:210 Page:217-229
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Moles Ernest,Urbán Patricia,Jiménez-Díaz María Belén,Viera-Morilla Sara,Angulo-Barturen Iñigo,Busquets Maria Antònia,Fernàndez-Busquets Xavier

Funder

Ministerio de Economía y Competitividad, Spain

Generalitat de Catalunya, Spain

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference65 articles.

1. Treatment of malaria in the United States: a systematic review;Griffith;JAMA,2007

2. Guidelines for the Treatment of Malaria;World Health Organization,2010

3. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria;Newton;Antimicrob. Agents Chemother.,2000

4. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency;Chan;BMJ,1976

5. On the mechanism of chloroquine resistance in Plasmodium falciparum;Chinappi;PLoS One,2010

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing liposome technology for innovative strategies against malaria;Saudi Pharmaceutical Journal;2024-06

2. Nanotherapeutics against malaria: A decade of advancements in experimental models;WIREs Nanomedicine and Nanobiotechnology;2024-03

3. Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer;2024-02-23

4. Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths;ACS Infectious Diseases;2024-02-06

5. Recent Advancements in Nanobiology in the Treatment of Human Diseases;Nanotechnology;2024